At the end of the 12 weeks, RB1CC1, ATG12, MAP1LC3B mRNA expression were estimated in the kidney of the 6 groups and were downregulated in the DKD group compared to the naïve group (3.8, 5.2 and 13 fold, respectively). This evidence concerns the gene RB1CC1 and diabetic kidney disease.